M. Gao

发表

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients

R. Bernards, C. Caldas, Mariette Schrier, 2019, Clinical Cancer Research.

Long non-coding RNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression by sponging miR-655-3p

Xue-hong Wang, Huimin Feng, Zhaoxia Wang, 2020 .

Metabolic control of histone acetylation for precise and timely regulation of minor ZGA in early mammalian embryos

C. Ding, Yan Zhang, Shaorong Gao, 2022, bioRxiv.

Modelling synergistic interactions between HER2, Sprouty2 and PTEN in driving prostate carcinogenesis.

I. Ahmad, H. Leung, Rachana Patel, 2013, Asian journal of andrology.

SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

J. Norman, O. Sansom, J. Edwards, 2012, EMBO molecular medicine.

Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.

O. Sansom, J. Edwards, I. Ahmad, 2013, The Journal of clinical investigation.

Sprouty 2 , PTEN , and PP 2 A interact to regulate prostate cancer progression

O. Sansom, J. Edwards, I. Ahmad, 2013 .

Activation of b-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer

A. Blomme, O. Sansom, J. Edwards, 2020 .

Activation of β-catenin cooperates with loss of Pten to drive AR-independent castration-resistant prostate cancer.

A. Blomme, O. Sansom, J. Edwards, 2019, Cancer research.

Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity

S. Samarajiwa, C. Martins, B. Hall, 2017, Genes & development.

A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival

N. Rosenfeld, S. Chin, C. Caldas, 2023, bioRxiv.

Predicting treatment resistance and relapse through circulating DNA.

C. Caldas, S. Sammut, E. Beddowes, 2017, Breast.

Efficacy and safety profile of avelumab monotherapy.

Hong Zhao, Bin Zhao, Xian Shen, 2021, Critical reviews in oncology/hematology.

lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p

Yuanyuan Cui, Xue-hong Wang, Huimin Feng, 2021, Open medicine.

Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA

S. Chin, C. Caldas, Linda Jones, 2018, bioRxiv.

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients

R. Bernards, C. Caldas, Mariette Schrier, 2019, Clinical Cancer Research.